Investors

Growing Shareholder Value

Press Releases

Clinical Data Highlights Advantages of Protected PCI to Enable Complete Revascularization and Improved Patient Quality of Life

Apr 23, 2019
Read More

Abiomed Fourth Quarter Fiscal 2019 Earnings and Conference Call Notification

Apr 11, 2019
Read More

Cardiogenic Shock Survival Rates Improve Significantly in Three Years Since Impella FDA PMA Approval

Apr 04, 2019
Read More

Impella RP Post-Approval Study Data Presented at ACC 2019

Mar 18, 2019
Read More

Benefits of Heart Recovery with Impella Showcased at ACC 2019

Mar 14, 2019
Read More

$100 Million Invested in Clinical Research for Impella

Feb 20, 2019
Read More

Impella Connect Achieves Regulatory Milestone

Jan 31, 2019
Read More

Abiomed Announces Q3 FY 2019 Record Revenue of $201 Million, up 30% over Prior Year

Jan 31, 2019
Read More

Abiomed Third Quarter Fiscal 2019 Earnings and Conference Call Notification

Jan 10, 2019
Read More

Abiomed Announces Preliminary Q3 FY 2019 Revenue of $201 Million, Up 30% Over Prior Year and Increases Full Year Guidance

Jan 07, 2019
Read More
View all